Viewing Study NCT05515406

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 1:19 PM
Ignite Modification Date: 2026-01-14 @ 5:06 AM
Study NCT ID: NCT05515406
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-19
First Post: 2022-08-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL
Sponsor: Ono Pharmaceutical Co. Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Non-Hodgkin View
None Leukemia, Lymphocytic, Chronic, B-Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ONO-7018, MALT1 inhibitor, Lymphoma, Leukemia View